Fridays @ 7:30 PM EST
Who's actually footing the bill for obesity drugs?
'Barron's Roundtable' panelists discuss questions remaining over obesity drug cost coverage and growing concerns over side effects.
'Barron's Roundtable' presents their autumn outlook for the markets
'Barron's Roundtable' panelists offer their market outlook heading into the autumn season.
Nvidia's numbers 'continually get amazing': Al Root
'Barron's Roundtable' panelists discuss Nvidia's earnings, Super Micro's sales and Vice President Kamala Harris' capital gains tax plan.
What are the setbacks in electric vehicle adoption?
'Barron's Roundtable' panelists discuss why some automakers are scaling back plans for electric vehicle rollouts.
Which retail stocks are winning with consumers?
'Barron's Roundtable' panelists discuss which stocks are performing best.
Breaking down 35 trillion reasons why Trump, Harris should be talking about national debt
'Barron's Roundtable' panelists discuss the U.S. federal debt topping $35 trillion with no plans to fix it.
Stocks jump as Fed chair Powell signals September rate cut
'Barron's Roundtable' panelists discuss a possible rate cut and three things investors ought to be thinking about right now.
Diamond business roiled by 'lab-grown' alternatives
'Barron's Roundtable' panelists discuss how the new alternative is hurting the diamond industry.
Chipotle sinks as Starbucks soars on CEO shakeup
'Barron's Roundtable' panelists offer their economic outlook and analyze Starbucks and Chipotle stock.
Expert details stocks with surprising returns
Research Affiliates founder and chairman Rob Arnott details the stocks with surprisingly lucrative returns on ‘Barron's Roundtable.’
We are listening for the signs of a Fed rate cut in September: Ben Levisohn
Barron's markets deputy editor Ben Levisohn analyzes the Federal Reserve's upcoming moves and stock market performance.
There has been a lot of 'whiplash' on Wall Street: Paul La Monica
The ‘Barron’s Roundtable’ panelists analyze whether the market turbulence will continue.
Tesla's stock is 'all about self-driving cars': Al Root
Barron's associate editor Al Root discusses Tesla's big steps toward 'robo driving' on 'Barron's Roundtable.'
Is the stock market attractively priced for long-term investors?
NYU Stern School of Business Finance Professor Aswath Damodaran discusses the outlook for tech stocks on 'Barron's Roundtable.'
What are the three things investors should be thinking about?
Jack Hough and ‘Barron’s Roundtable’ panelists highlight the three things investors should be considering heading into the next week.
How Merck plans to fill the void of Keytruda patent expiration
'Barron's Roundtable' panelists discuss Wall Street's favorite drug stocks and offer a market outlook.
Should you be bullish on Amgen?
'Barron's Roundtable' panelists discuss how you can prepare your portfolio if interest rates come down and if you should 'buy the dip' in Chipotle stock.
How has Ralph Lauren’s Olympics marketing impacted the company?
Telsey Advisory Group CEO Dana Telsey discusses the impact of Ralph Lauren’s Team USA Olympic uniforms on the company’s stock on ‘Barron’s Roundtable.’
This is an AI arms race: Elizabeth O'Brien
'Barron's Roundtable' discusses artificial intelligence, the Intel stock plunge and Boeing's headwinds.
Here's why investors are 'eyeing' next week's Federal Reserve meeting
'Barron's Roundtable' panelists discuss ongoing market rotation, small caps garnering attention and expected remarks on cryptocurrency by former President Trump.